Ftse Mib
35.854,07
-0,57%
DAX
21.303,82
1,25%
S&P 500
0,00
0,00%
NASDAQ
20.009,34
1,28%
Bitcoin
102.500,00
-1,10%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Bivictrix Therapeutics Plc (BVX) Bivictrix Therapeutics Plc (BVX) Notizie

Bivictrix Therapeutics Plc

BVX
10,00
0,00 (0,00%)
22 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
11/9/202408:00LSEG_RNSAIM Cancellation - BiVictriX Therapeutics plc
10/9/202412:04LSEG_RNSBiVictriX Therapeutics PLC Holding(s) in Company
10/9/202408:00LSEG_RNSBiVictriX Therapeutics PLC Last Day of Dealings
09/9/202416:35ALNCNewsBivictrix Therapeutics optimistic about BVX002 after in vivo..
09/9/202408:00LSEG_RNSBiVictriX Therapeutics PLC Positive In Vivo Data from BVX002..
02/9/202418:04LSEG_RNSBiVictriX Therapeutics PLC Holding(s) in Company
02/9/202409:50LSEG_RNSBiVictriX Therapeutics PLC Director Dealing
29/8/202418:05LSEG_RNSBiVictriX Therapeutics PLC Result of General Meeting
28/8/202411:14LSEG_RNSBiVictriX Therapeutics PLC Holding(s) in Company
28/8/202411:12LSEG_RNSBiVictriX Therapeutics PLC Holding(s) in Company
19/8/202408:00LSEG_RNSBiVictriX Therapeutics PLC TR-1: Notification of major..
13/8/202408:00LSEG_RNSBiVictriX Therapeutics PLC Grant of Options
12/8/202411:58ALNCNewsBivictrix Therapeutics to delist as AIM offers insufficient..
12/8/202408:00LSEG_RNSBiVictriX Therapeutics PLC Proposed Voluntary Delisting
01/8/202408:00LSEG_RNSBiVictriX Therapeutics PLC Interim Results
24/7/202418:00LSEG_RNSBiVictriX Therapeutics PLC Result of Annual General Meeting
26/6/202408:00LSEG_RNSBiVictriX Therapeutics PLC Publication of 2023 Annual Report..
13/6/202420:40ALNCNewsEARNINGS AND TRADING: Dialight trades in line; Petards..
13/6/202408:00LSEG_RNSBiVictriX Therapeutics PLC Compelling Safety Profile of..
06/6/202408:00LSEG_RNSBiVictriX Therapeutics PLC Innovate UK Grant Award to..
31/5/202420:00ALNCNewsEARNINGS AND TRADING: CT UK High Income tops benchmark, ups..
31/5/202409:44LSEG_RNSBiVictriX Therapeutics PLC BiVictriX – Full Year Results..
17/4/202415:23ALNCNewsBivictrix granted FDA orphan drug status for rare cancer..
17/4/202408:00LSEG_RNSBiVictriX Therapeutics PLC Orphan Drug Designation & FDA..
28/3/202408:00LSEG_RNSBiVictriX Therapeutics PLC Grant of Options – PDMR/Director..
Apertura: Min: Max:
Chiusura: 10,00

La tua Cronologia

LSE
BVX
Bivictrix Therapeutics
BOV
TGMA3R
TEGMA ON
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network